‘Publish or perish’ culture blamed for reproducibility crisis
Nature – Survey of more than 1,600 biomedical researchers also flagged small sample sizes and cherry-picking of data as leading causes of reproducibility problems.
Related Articles
People are bad at reporting what they eat. That’s a problem for dietary research
Studies that use surveys to link dietary patterns to human health may be irredeemably biased, new paper suggests
Epidemiology of Small Cell Lung Cancer in the U.S. from 2000 to 2019: A Study Utilizing the SEER Registry
From the late 1980s to 2000, small cell lung cancer (SCLC) represented a decreasing proportion of lung cancer in the United States. Survival outcomes in…
Goal-Concordant Location of Death in Adolescents and Young Adults With Cancer
This cohort study assesses how often young adults and adolescents with cancer are engaged in discussion about their preferred location of death and whether the…
Logical Fallacies and Statistical Anomalies Trick You Into Believing Untrue Things
No, Nicolas Cage isn’t trying to drown you.
Food and medicine that can change your skin colour – sometimes permanently
Your skin can often take on the hue of what you digest.
Saving lives and limbs on the high seas: the extraordinary world of early modern ship’s surgeons
They battled scurvy, amputated limbs and treated deadly fevers, all while enduring the chaos of storms and warfare.
How to fix democracy? Ancient philosopher Plato may have an answer
Ruling is a skilled trade, Plato argues. And like any other trade, not everyone has the talent or the training to be good at it.
Some Assembly Required
The IKEA effect and my new carOnce upon a time, when you bought a car, all you needed to know was where the gear shift…
Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines
Objectives Should a young person receive psychotherapy or medication for their depression and on what evidence do we base this decision? In this paper, we…
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
This randomized clinical trial evaluates the efficacy and safety of first-line toripalimab vs placebo plus etoposide and platinum-based chemotherapy for treating patients with extensive-stage small…
